Beciparcil
- Level
- Commodity
- Parent
- 51131600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51131623This classification denotes an anticoagulant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K90ZOR23P1. European Medicines Agency schedules Beciparcil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05674MIG. Beciparcil generally arises in the molecular formula C12H13NO3S2. The term BECIPARCIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 8 no. 3 1994, list 34.) BECIPARCIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule beciparcil under HS 29349990 and SITC 51579. As of Q4 2014, BECIPARCIL remains the US FDA Preferred Term for this commodity. Beciparcil bears US NLM identifiers UMLS ID C0761070 and NCI Concept Code C73225. SMILES: C1C(C(C(C(S1)SC2=CC=C(C=C2)C#N)O)O)O.
Same parent
Under 51131600 · 61Activities that produce or sell this
KBLI · 8Inherited from family 51130000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.